Multi-State Divestitures Delay Cresco-Columbia Merger
Cresco Labs’ $2 billion acquisition of Columbia Care has been pushed back to this summer, but that should not be a surprise given the bureaucratic and logistic... Read more.
Curaleaf’s Undisclosed Ties to Sanctioned Oligarch Spur Regulatory Scrutiny
Curaleaf is betting its survival on the nascent East Coast markets, but could new investigations in at least three northeastern states strike a fatal blow to one... Read more.
Social Equity Fund’s Financing Woes Could Further Delay New York’s Slow Adult-Use Start
Questions about New York’s cannabis social equity fund persist months after missing the Sept. 1, 2022, deadline to secure $150 million in financing. The fund,... Read more.
